Press release
Elevated Ovarian Cancer Incidence Fuels Growth In The Endometriosis Market: A Key Driver Powering Endometriosis Market Growth In 2025
Endometriosis Market
What Is the Current Endometriosis Market Size and Its Estimated Growth Rate?
In recent years, there has been a swift expansion in the market size of endometriosis. This market is projected to increase from $1.4 billion in 2024 to $1.55 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.2%. The growth observed in the past can be tied to factors such as delayed diagnosis and raised awareness, advancements in laparoscopic surgery, hormonal treatments, as well as the presence of patient advocacy and support groups.
In the coming years, the endometriosis market is projected to experience significant expansion. It is predicted to reach $2.21 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.3%. Causes for this anticipated growth during the forecast period encompass advancements in minimally invasive procedures, pharmaceutical innovations, and genetic and epigenetic research, as well as the worldwide expansion of women's healthcare. Leading trends for this period are predicted to be patient-focused care, precision medicine, digital health services, including virtual care and telemedicine, and fertility preservation.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13035
How Are Emerging Segments Shaping the Endometriosis Market Landscape?
The endometriosis market covered in this report is segmented -
1) By Type: Superficial Peritoneal Lesion, Endometrioma, Deeply Infiltrating Endometriosis, Other Types
2) By Treatment Type: Hormonal Therapy, Pain Management
3) By Drug: Oral Contraceptives, Progestins, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Gonadotropin Releasing Hormone (GnRH) Analogues, Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs), Other Drugs
4) By End-User: Hospitals, Homecare, Specialty Centers, Other End-Users
Subsegments:
1) By Superficial Peritoneal Lesion: Endometriotic Nodules, Peritoneal Endometriosis
2) By Endometrioma: Chocolate Cysts
3) By Deeply Infiltrating Endometriosis: Bowel Endometriosis, Ureteral Endometriosis, Vaginal Endometriosis
4) By Other Types: Abdominal Endometriosis, Thoracic Endometriosis
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13035&type=smp
Which Growth Factors Are Influencing Endometriosis Market Expansion?
The surge in cases of ovarian cancer is expected to fuel the expansion of the endometriosis market. Ovarian cancer, a disease usually originating in the ovaries, has ties to endometriosis due to their shared link with elevated estrogen levels. The result is an amplified possibility of the development of specific subtypes of ovarian cancer, including endometrioid and clear cell cancer. The American Cancer Society anticipates that the year 2023 will witness the detection of about 19,710 new instances of ovarian cancer specifically among women in the US, as per their statistics from January 2023. In addition, data from the Ovarian Cancer Research Alliance in 2022 reveals that the disease claimed 12,810 lives in 2022, a figure that escalated to 13,270 in 2023. Consequently, this rise in ovarian cancer occurrence has been providing impetus to the endometriosis market's growth. As far as the endometriosis market drivers are concerned, a significant increase in government funding has been instrumental in steering the growth of the market. The term government funding denotes the monetary support rendered to non-government organizations, with funds being channelled either fully or partly by the government. Resources for pursuing endometriosis research, typically disbursed as grants and contracts, are given to individual scientists or research institutions conducting clinical studies. To illustrate, in March 2022, the Federal Government of the United States allocated $92 million to the National Institute of Child Health and Human Development (NICHD) while upholding its $370 million funding for the Department of Defense's Peer-Reviewed Medical Research Programme (PRMRP) committed to advancing endometriosis research. Therefore, it is the escalation in government funding that steers the growth of the endometriosis market.
Who Are the Dominant Players Across Different Endometriosis Market Segments?
Major companies operating in the endometriosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck And Co. Inc., Abbvie Inc., Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Ipsen Pharma Biotech S.A.S., Cadila Pharmaceuticals Ltd., Gedeon Richter PLC, Torrent Pharmaceuticals Ltd., Neurocrine Biosciences Inc., Ferring Pharmaceuticals, Prestige Consumer Healthcare Inc., Almirall S.A, Evotec BioSystems GmbH, Serum Institute of India Pvt. Ltd., Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., DebioPharm Group, Repros Therapeutics Inc., Meditrina Pharmaceuticals Private Limited, Zenomed Healthcare Private Limited.
What Are the Latest Developing Trends in the Endometriosis Market?
Leading corporations in the endometriosis market are concentrating their efforts on the creation of innovative medications like Myfembree and securing necessary approvals to offer novel treatment alternatives for patients. The advent of new endometriosis drugs fulfills an unmet need for effective treatment methods. For example, in August 2022, Myovant Sciences GmbH, a biopharmaceutical firm based in Switzerland, and Pfizer Inc., an American pharmaceutical industry company, obtained clearance from the U.S. Food and Drug Administration (FDA) for the use of Myfembree in managing moderate to severe pain in premenopausal women with endometriosis. Myfembree, a once-daily pill, integrates three vital components: relugolix, estradiol, and norethindrone acetate and has been proven effective in providing relief for premenopausal women, offering dual benefits in one pill. This introduces a new treatment possibility for women who are unable or choose not to use hormone therapy.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/endometriosis-global-market-report
Which Geographic Regions Are Expected to Dominate the Endometriosis Market in the Coming Years?
North America was the largest region in the endometriosis market in 2024. The regions covered in endometriosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Endometriosis Market?
2. What is the CAGR expected in the Endometriosis Market?
3. What Are the Key Innovations Transforming the Endometriosis Industry?
4. Which Region Is Leading the Endometriosis Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Elevated Ovarian Cancer Incidence Fuels Growth In The Endometriosis Market: A Key Driver Powering Endometriosis Market Growth In 2025 here
News-ID: 4022893 • Views: …
More Releases from The Business Research Company
Competitive Landscape: Key Market Leaders and Emerging Participants in the Ultra …
The demand for ultra pure water is on a sharp rise, driven by its critical role across multiple high-tech and industrial sectors. As industries continue to advance, ensuring the availability of water free from contaminants becomes increasingly vital. Let us explore the current market outlook, key players, emerging trends, and segment details shaping the ultra pure water market's future.
Expected Market Size and Growth Outlook for Ultra Pure Water
The ultra…
Future Perspectives: Key Trends Shaping the Styrene-Petrochemicals Market Up to …
The styrene-petrochemicals sector is positioned for steady expansion in the coming years, driven by diverse industrial demands and evolving market trends. Understanding the current landscape, key players, and emerging innovations sheds light on the future trajectory of this important chemical market.
Expected Growth and Market Size of the Styrene-Petrochemicals Industry
The styrene-petrochemicals market is projected to reach a value of $82.11 billion by 2029, growing at a compound annual growth rate…
Segmentation, Main Trends, and Competitive Overview of the Silicone Market
The silicone market is poised for significant expansion over the coming years, driven by various technological and environmental factors. This sector is rapidly evolving to meet the rising demand across multiple industries, fueled by innovations and sustainability trends. Let's explore the market's size, key players, growth drivers, emerging trends, and segmentation to understand the future outlook better.
Projected Expansion of the Silicone Market by 2029
The silicone market is expected to…
Competitive Landscape: Leading Companies and New Entrants in the Printing Inks M …
The printing inks market is on a steady upward path, driven by evolving technological innovations and growing demands from various industries. As the need for sustainable and efficient printing solutions increases, this sector is poised for significant expansion in the coming years. Below is a detailed overview of the market size, key players, trends, and segmentation shaping the future of printing inks.
Expected Market Size and Growth Prospects of the Printing…
More Releases for Endometriosis
Endometriosis Treatment Market at $1.55B, 7.7% CAGR
Why Is the Global Endometriosis Treatment Market Expanding So Quickly?
The endometriosis treatment market has grown rapidly in recent years, primarily due to increased awareness, better diagnostic technologies, rising cases of reproductive health disorders, and significant investment in research and drug development. With the market valued at USD 1.55 billion in 2024 and expected to reach USD 3.25 billion by 2034, the global demand for effective treatments continues to accelerate.
Endometriosis affects…
Endometriosis Pain Market Massive Growth opportunity Ahead
Introduction
Endometriosis is a chronic, estrogen-dependent condition in which endometrial-like tissue grows outside the uterus, leading to inflammation, scarring, and adhesions. One of its most debilitating symptoms is pelvic pain, often accompanied by painful periods, infertility, and fatigue. Globally, endometriosis affects an estimated 10% of women of reproductive age, making it a major public health concern.
Despite its prevalence, endometriosis pain has historically been underdiagnosed and undertreated. Patients often face diagnostic delays…
Hope for Rapid, Non-Invasive Endometriosis Diagnosis
New diagnostic test for endometriosis, the ENDOSURE test, offers decision support to clinicians with 99.87% accurate results in less than an hour, could transform women's healthcare
EDMONTON, AB - In a groundbreaking development for women's health featured on Global News Calgary by journalist Jayme Doll on March 12, 2025, the ENDOSURE test emerges as a beacon of hope for millions suffering from undiagnosed endometriosis in. This non-invasive diagnostic tool promises to…
Emerging Endometriosis Market Trend 2025-2034: Innovative Medications Reshaping …
"How Is the Endometriosis Market Projected to Grow, and What Is Its Market Size?
The endometriosis market has seen rapid growth in recent years. It is expected to grow from $1.4 billion in 2024 to $1.55 billion in 2025, at a compound annual growth rate (CAGR) of 10.2%. The growth can be attributed to delayed diagnosis, increased awareness, advances in laparoscopic surgery, hormonal therapies, and the support of patient advocacy groups.
The…
Endometriosis Treatment Market Analysis, Size, Share & Trends | 2031
In recent years, the global Endometriosis Treatment Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Endometriosis Treatment Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five…
Endometriosis Market Trends, Size, Forecast - 2018-2023
Endometriosis is a painful disorder in which the layer of tissue that normally surfaces inside the uterus, starts growing outside the uterus. This mainly occurs on the fallopian tubes, ovaries, and tissue around the uterus; however, in exceptional cases it may occur in other parts of the body. The endometriosis leads to various physical symptoms such as severe menstrual cramps, nausea and vomiting, fatigue, diarrhea, constipation, long-term pelvic pain, and…
